M. Casi

549 total citations
16 papers, 403 citations indexed

About

M. Casi is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics and Oncology. According to data from OpenAlex, M. Casi has authored 16 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Genetics and 4 papers in Oncology. Recurrent topics in M. Casi's work include Radiopharmaceutical Chemistry and Applications (13 papers), Medical Imaging Techniques and Applications (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). M. Casi is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (13 papers), Medical Imaging Techniques and Applications (7 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). M. Casi collaborates with scholars based in Italy. M. Casi's co-authors include G. Franceschi, N. Riva, M. Frattarelli, Paola Riva, A. Arista, Carmelo Lucio Sturiale, G Giuliani, Monica Santimaria, Pietro Riva and Anna Maria Cremonini and has published in prestigious journals such as Cancer, Scientific Reports and European Journal of Cancer.

In The Last Decade

M. Casi

16 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Casi Italy 9 262 121 118 72 72 16 403
Xiao-Guang Zhao United States 9 274 1.0× 117 1.0× 145 1.2× 80 1.1× 83 1.2× 11 455
N. Riva Italy 11 301 1.1× 150 1.2× 132 1.1× 77 1.1× 81 1.1× 17 488
G. Franceschi Italy 12 317 1.2× 146 1.2× 131 1.1× 77 1.1× 79 1.1× 17 491
Edward V. Colapinto United States 11 252 1.0× 97 0.8× 46 0.4× 104 1.4× 43 0.6× 13 434
Abraham Boskovitz United States 7 98 0.4× 84 0.7× 127 1.1× 49 0.7× 44 0.6× 8 352
Zi-Fen Su Canada 8 192 0.7× 104 0.9× 56 0.5× 20 0.3× 88 1.2× 15 349
R. Blasberg United States 8 173 0.7× 93 0.8× 59 0.5× 26 0.4× 61 0.8× 13 429
J.A. MacKinnon Canada 3 69 0.3× 50 0.4× 232 2.0× 38 0.5× 86 1.2× 3 315
Anna N. Cvrljevic Australia 5 62 0.2× 161 1.3× 117 1.0× 17 0.2× 61 0.8× 6 391
Allan James United Kingdom 10 92 0.4× 164 1.4× 146 1.2× 22 0.3× 79 1.1× 30 433

Countries citing papers authored by M. Casi

Since Specialization
Citations

This map shows the geographic impact of M. Casi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Casi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Casi more than expected).

Fields of papers citing papers by M. Casi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Casi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Casi. The network helps show where M. Casi may publish in the future.

Co-authorship network of co-authors of M. Casi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Casi. A scholar is included among the top collaborators of M. Casi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Casi. M. Casi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Palleschi, Michela, Andrea Prochowski Iamurri, Emanuela Scarpi, et al.. (2022). Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab. Scientific Reports. 12(1). 3385–3385. 6 indexed citations
3.
Casi, M., et al.. (2016). 90Y-PET/CT imaging quantification in peptide receptor radionuclide therapy (PRRT). Physica Medica. 32. 105–105. 1 indexed citations
4.
Bartolomei, Mirco, et al.. (2015). 90 Y-PET/CT Imaging Quantification for Dosimetry in Peptide Receptor Radionuclide Therapy: Analysis and Corrections of the Impairing Factors. Cancer Biotherapy and Radiopharmaceuticals. 30(5). 200–210. 5 indexed citations
5.
Casi, M., et al.. (2012). 90Y-based PET and SPECT/CT imaging in locoregional brain treatment for high-grade gliomas: retrospective fusion with MRI. European Journal of Nuclear Medicine and Molecular Imaging. 39(11). 1822–1823. 3 indexed citations
6.
Fabbri, Carlo, M. Casi, Marco Agostini, et al.. (2012). Quantitative evaluation on [⁹⁰Y] DOTATOC PET and SPECT imaging by phantom acquisitions and clinical applications in locoregional and systemic treatments.. PubMed. 56(6). 522–8. 8 indexed citations
7.
Riva, Paola, G. Franceschi, N. Riva, et al.. (2000). Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach. European Journal of Nuclear Medicine and Molecular Imaging. 27(5). 601–609. 57 indexed citations
8.
Riva, Paola, G. Franceschi, M. Frattarelli, et al.. (1999). Loco-regional radioimmunotherapy of high-grade malignant gliomas using specific monoclonal antibodies labeled with 90Y: a phase I study.. PubMed. 5(10 Suppl). 3275s–3280s. 61 indexed citations
9.
Riva, Paola, G. Franceschi, A. Arista, et al.. (1997). Local application of radiolabeled monoclonal antibodies in the treatment of high grade malignant gliomas. Cancer. 80(S12). 2733–2742. 52 indexed citations
10.
Riva, Pietro, et al.. (1997). Radioimmunodetection and Radioimmunotherapy of Breast Cancer. Tumori Journal. 83(2). 552–557. 2 indexed citations
11.
Riva, Pietro, G. Franceschi, A. Arista, et al.. (1997). Local application of radiolabeled monoclonal antibodies in the treatment of high grade malignant gliomas. Cancer. 80(S12). 2733–2742. 42 indexed citations
12.
Riva, Paola, A. Arista, G. Franceschi, et al.. (1995). Local treatment of malignant gliomas by direct infusion of specific monoclonal antibodies labeled with 131I: comparison of the results obtained in recurrent and newly diagnosed tumors.. PubMed. 55(23 Suppl). 5952s–5956s. 56 indexed citations
13.
Riva, Paola, Carmelo Lucio Sturiale, A. Arista, et al.. (1995). 263 Intralesional radioimmunotherapy of malignant gliomas as adjuvant setting in newly diagnosed tumour or as rescue treatment in recurrent lesions. European Journal of Cancer. 31. S58–S58. 1 indexed citations
14.
Riva, Paola, A. Arista, Carmelo Lucio Sturiale, et al.. (1994). Glioblastoma therapy by direct intralesional administration of I-131 radioiodine labeled antitenascin antibodies. Cell Biophysics. 24-25(1-3). 37–43. 15 indexed citations
15.
Riva, Pietro, A. Arista, V. Tison, et al.. (1994). Intralesional radioimmunotherapy of malignant gliomas. An effective treatment in recurrent tumors. Cancer. 73(S3). 1076–1082. 76 indexed citations
16.
Riva, Paola, V. Tison, A. Arista, et al.. (1993). Radioimmunotherapy of Gastrointestinal Cancer and Glioblastomas. The International Journal of Biological Markers. 8(3). 192–197. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026